However, treatment with inhibitors of histone deacetylases has been shown to reverse the epigenetic repression of the ERV9 LTR promoters, leading to induction of TP63 and TNFRSF10B transcription and ultimately promoting apoptosis of testicular cancer cells [74,75]. This evidence concerns the gene TP63 and testicular cancer.